Top Buy
Security | Buy | Sell | Buy (1M) | Sell (1M) | Price ▲ | Target price | Potential |
---|---|---|---|---|---|---|---|
QIAGEN NV | 9 | 0 | 0 | 0 | €40.47 | €47.44 | 17.223% |
Laboratorios Farmaceuticos | 1 | 0 | 0 | 0 | €83.10 | €100.00 | 20.337% |
Heidelberg Pharma AG | 3 | 0 | 0 | 0 | €2.99 | - | - |
Geron Corp. | 12 | 0 | 4 | 0 | €3.65 | €4.63 | 26.838% |
Xencor Inc. | 9 | 1 | 1 | 0 | €18.70 | €31.74 | 69.727% |
Fate Therapeutics Inc. | 5 | 2 | 2 | 1 | €3.78 | €8.27 | 118.625% |
Charles River Labs Intl | 9 | 0 | 0 | 0 | €216.90 | €247.61 | 14.157% |
Exelixis Inc. | 18 | 0 | 3 | 0 | €20.62 | €26.01 | 26.122% |
Anika Therapeutics | 4 | 0 | 0 | 0 | €24.60 | €26.58 | 8.054% |
Corcept Therapeutics Inc. | 11 | 0 | 4 | 0 | €22.80 | €35.43 | 55.392% |
Neurocrine Bioscience | 27 | 0 | 7 | 0 | €130.70 | €140.34 | 7.376% |
AnaptysBio Inc | 8 | 1 | 3 | 0 | €24.80 | €46.24 | 86.452% |
X4 Pharmaceuticals, Inc. | 6 | 1 | 3 | 1 | €1.07 | €2.78 | 158.705% |
Viking Therapeutics Inc | 6 | 0 | 3 | 0 | €71.48 | €100.00 | 39.899% |
SCYNEXIS Inc. | 5 | 0 | 1 | 0 | €1.66 | €3.00 | 80.723% |
Lexicon Pharmaceuticals Inc. | 2 | 0 | 1 | 0 | €1.61 | €5.34 | 231.017% |
Immunogen Inc. | 5 | 0 | 1 | 0 | €28.97 | - | - |
Enanta Pharmaceuticals Inc. | 5 | 4 | 0 | 1 | €12.70 | €26.92 | 111.996% |
Insmed Inc. | 13 | 1 | 2 | 1 | €23.80 | €44.01 | 84.902% |
Rigel Pharmaceutical Inc. | 9 | 0 | 0 | 0 | €1.11 | €13.74 | 1136.922% |
Actinium Pharmaceuticals Inc. | 4 | 0 | 2 | 0 | €8.28 | €8.50 | 2.719% |
Amneal Pharmaceuticals Inc | 1 | 1 | 1 | 0 | €5.80 | €10.00 | 72.414% |
Savara Inc. | 1 | 0 | 1 | 0 | €4.16 | €8.00 | 92.308% |
Catalent Inc. | 2 | 0 | 0 | 0 | €52.32 | €55.00 | 5.122% |
Hutchison China MediTech Ltd ADR | 5 | 0 | 0 | 0 | €18.30 | €45.10 | 146.421% |